APA (7th ed.) Citation

Farid, K., Sauer, T., Schmitt, M., Müller-Tidow, C., & Schmitt, A. (2024). Symptomatic patients with hyperleukocytic FLT3-ITD mutated acute myeloid leukemia might benefit from leukapheresis. Cancers, 16(1), . https://doi.org/10.3390/cancers16010058

Chicago Style (17th ed.) Citation

Farid, Kiavasch, Tim Sauer, Michael Schmitt, Carsten Müller-Tidow, and Anita Schmitt. "Symptomatic Patients with Hyperleukocytic FLT3-ITD Mutated Acute Myeloid Leukemia Might Benefit from Leukapheresis." Cancers 16, no. 1 (2024). https://doi.org/10.3390/cancers16010058.

MLA (9th ed.) Citation

Farid, Kiavasch, et al. "Symptomatic Patients with Hyperleukocytic FLT3-ITD Mutated Acute Myeloid Leukemia Might Benefit from Leukapheresis." Cancers, vol. 16, no. 1, 2024, https://doi.org/10.3390/cancers16010058.